Abstract:Connexin 43 (Cx43) is most widely distributed in mammals, especially in the cardiovascular and nervous systems. Its phosphorylation state has been found to be regulated by the action of more than ten kinases and phosphatases, including mitogen-activated protein kinase/extracellular signaling and regulating kinase signaling. In addition, the phosphorylation status of different phosphorylation sites affects its own synthesis and assembly and the function of the gap junctions (GJs) to varying degrees. The phosphorylation of Cx43 can affect the permeability, electrical conductivity, and gating properties of GJs, thereby having various effects on intercellular communication and affecting physiological or pathological processes in vitro and in vivo. Therefore, clarifying the relationship between Cx43 phosphorylation and specific disease processes will help us better understand the disease. Based on the above clinical and preclinical findings, we present in this review the functional significance of Cx43 phosphorylation in multiple diseases and discuss the potential of Cx43 as a drug target in Cx43-related disease pathophysiology, with an emphasis on the importance of connexin 43 as an emerging therapeutic target in cardiac and neuroprotection.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of the phosphorylation state of Connexin 43 (Cx43) in various diseases and its potential therapeutic significance. Specifically, the paper focuses on how the phosphorylation of Cx43 affects its function, especially its role in cardiovascular and nervous system diseases. By reviewing the functional significance of Cx43 phosphorylation, the author aims to reveal the potential of Cx43 as a drug target in the pathophysiology of related diseases, with special emphasis on the importance of Cx43 in cardioprotection and neuroprotection. ### Main research questions: 1. **The role of Cx43 phosphorylation in diseases**: The paper explores how Cx43 phosphorylation affects inter - cellular communication, especially through the functional changes of Gap Junctions (GJs) and Hemichannels, thus affecting physiological or pathological processes. 2. **The relationship between Cx43 phosphorylation and specific diseases**: The paper discusses in detail the specific roles of Cx43 phosphorylation in various diseases, including depression, Alzheimer's disease, Parkinson's disease, epilepsy, and ischemic stroke. 3. **The potential of Cx43 as a drug target**: The paper evaluates the possibility of Cx43 as a therapeutic target, especially in the treatment of cardiovascular and nervous system diseases. ### Specific research contents: - **Depression**: Research has found that corticosterone (CORT) can reduce the distribution of Cx43 on the cell membrane and enhance its phosphorylation at Ser368, leading to inter - cellular communication disorders. In addition, it has also been found that ginsenoside Rg1 can improve depressive symptoms by reversing the phosphorylation of Cx43 at Tyr265 and Ser279. - **Alzheimer's disease**: The expression of Cx43 in the brains of AD patients increases, and its phosphorylation at Ser368 is enhanced, leading to an increase in hemichannel activity and ATP release. The A2A receptor (A2AR) can regulate the phosphorylation of Cx43 and inhibit its over - activation. - **Parkinson's disease**: In the rotenone - induced Parkinson's disease model, both the Cx43 protein level and the phosphorylation level increase, especially in the basal ganglia region. Cx43 is mainly phosphorylated at Ser368, leading to inter - cellular communication dysfunction. - **Epilepsy**: The phosphorylation state of Cx43 plays an important role in epilepsy. In particular, the phosphorylation at Ser365 and Ser368 can increase the junctional conductance, leading to the release of potassium ions (K+) and glutamate (Glu). - **Ischemic stroke**: In ischemic stroke, the phosphorylation of Cx43 may lead to the degradation of gap junctions and the opening of hemichannels, promoting the release of inflammatory mediators. In addition, the dephosphorylation of Cx43 may also lead to the opening of hemichannels, further exacerbating neuroinflammation. Through these studies, the paper aims to clarify the specific mechanisms of Cx43 phosphorylation in various diseases and provide a theoretical basis for the development of new treatment methods.

Connexin 43 Phosphorylation: Implications in Multiple Diseases

Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders

Phosphorylation-dependent allosteric regulation of Cx43 gap junction inhibitor potency

Connexin 43, a new therapeutic target for cardiovascular diseases

Connexin 43 and Mitochondria in Cardiovascular Health and Disease

Functional analysis and regulation of purified connexin hemichannels

Peptidic Connexin43 Therapeutics in Cardiac Reparative Medicine

Role of connexin 43 in cardiovascular diseases

Evaluating the role of connexin 43 in congenital heart disease : and the analysis of knockin mouse models

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

Connexin Hemichannels in Astrocytes: Role in CNS Disorders

Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection

Stimulation of cardiac beta-adrenoceptors targets connexin 43

Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease

Mutation of Human Connexin43 Amino Acids S279/S282 Increases Protein Stability Upon Treatment with Epidermal Growth Factor

Interacting Network of the Gap Junction (GJ) Protein Connexin43 (Cx43) is Modulated by Ischemia and Reperfusion in the Heart*

Role of Connexins 30, 36, and 43 in Brain Tumors, Neurodegenerative Diseases, and Neuroprotection

Regulation of gap junction intercellular communication by connexin ubiquitination: physiological and pathophysiological implications

Perspective and Therapeutic Potential of the Noncoding RNA–Connexin Axis

Functional consequences of abnormal Cx43 expression in the heart

Connexin43 and Myocardial Ischemia-Reperfusion Injury.